180 related articles for article (PubMed ID: 15592528)
1. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.
Sato N; Parker AR; Fukushima N; Miyagi Y; Iacobuzio-Donahue CA; Eshleman JR; Goggins M
Oncogene; 2005 Jan; 24(5):850-8. PubMed ID: 15592528
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
4. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
9. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
Sato N; Maitra A; Fukushima N; van Heek NT; Matsubayashi H; Iacobuzio-Donahue CA; Rosty C; Goggins M
Cancer Res; 2003 Jul; 63(14):4158-66. PubMed ID: 12874021
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
[TBL] [Abstract][Full Text] [Related]
12. Methylation of TFPI-2 gene is not the sole cause of its silencing.
Rao CN; Segawa T; Navari JR; Xu L; Srivastava S; Moul JW; Phillips B
Int J Oncol; 2003 Apr; 22(4):843-8. PubMed ID: 12632077
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
Hubé F; Reverdiau P; Iochmann S; Rollin J; Cherpi-Antar C; Gruel Y
Biol Chem; 2003 Jul; 384(7):1029-34. PubMed ID: 12956419
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.
Jansen M; Fukushima N; Rosty C; Walter K; Altink R; Heek TV; Hruban R; Offerhaus JG; Goggins M
Cancer Biol Ther; 2002; 1(3):293-6. PubMed ID: 12432281
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas.
Sato N; Goggins M
J Hepatobiliary Pancreat Surg; 2006; 13(4):280-5. PubMed ID: 16858538
[TBL] [Abstract][Full Text] [Related]
18. Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.
Steiner FA; Hong JA; Fischette MR; Beer DG; Guo ZS; Chen GA; Weiser TS; Kassis ES; Nguyen DM; Lee S; Trepel JB; Schrump DS
Oncogene; 2005 Mar; 24(14):2386-97. PubMed ID: 15735751
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
Okami J; Simeone DM; Logsdon CD
Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
